Patent details

EP0524579 Title: Improved oral dosing formulations of dideoxy purine nucleosides

Basic Information

Publication number:
EP0524579
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP921123717
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Improved oral dosing formulations of dideoxy purine nucleosides
French Title of Invention:
Formulations orales dosées et améliorées de dideoxy purine nucléosides
German Title of Invention:
Verbesserte und dosierte orale Formulierungen von Dideoxypurinenukleosiden
SPC Number:

Dates

Filing date:
20/07/1992
Grant date:
11/03/1998
EP Publication Date:
11/03/1998
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/01/1993
EP B1 Publication Date:
11/03/1998
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/07/2012
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/07/1992
 
 

Name:
BRISTOL-MYERS SQUIBB COMPANY
Address:
PARK AVENUE 345, NEW YORK, N.Y. 10154, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/03/1998
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Wiley Gary James
Address:
United States (US)

2

Name:
Agharkar Shreeram Narahari
Address:
United States (US)

3

Name:
Ullah Ismat
Address:
United States (US)

Priority

1

Priority Number:
733547
Priority Date:
22/07/1991
Priority Country:
United States (US)

2

Priority Number:
882204
Priority Date:
13/05/1992
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/70;
Filing date Document type Number of pages